GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ace (ACE) [hlAlert]

Rating:
Outperform
ACE
up 87.00 %

Ace (ACE) upgraded to Outperform by Wachovia

Posted on: Tuesday,  Jul 8, 2008  8:25 AM ET by Wachovia

Wachovia rated Outperform Ace (NYSE: ACE) on 07/08/2008, when the stock price was $55.42. Since then,
Ace has gained 87.01% as of 01/05/2016's recent price of $103.64.
If you would have followed this Wachovia's recommendation on ACE, you would have gained 87% of your investment in 2737 days.

Alcon, Inc. is the world's leading eye care company. Alcon, which has been dedicated to the ophthalmic industry for sixty years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. All trademarks noted in this release are the property of Alcon, Inc., with the exception of Ciprodex, which is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG. Moxifloxacin is licensed to Alcon, Inc. by Bayer Healthcare AG.

Wachovia offers a full range of products and services to meet the needs of corporate and institutional clients nationwide. These include capital raising, market making, and financial advisory products and services, to name just a few. We have the experience and resources you need to help your business grow and succeed. With a unified culture and integrated platform, ours is an organization that executes without distraction. We are focused and proactive, working as a team to deliver the ideas and capital for your needs.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/8/2008 8:25 AM Buy
None
55.42
as of 12/24/2008
1 Week down  -4.26 %
1 Month up  15.03 %
3 Months down  -0.29 %
1 YTD down  -22.11 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/2/2007 9:25 AM Hold
None
61.68

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy